Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida.

Published in: Diseases (Basel, Switzerland) (2018)

These findings demonstrated good tolerability of DAAs in HIV/HCV coinfected patients. More real-world studies are needed to explore the variables that are associated with AE.

Keyphrases

hepatitis c virus
end stage renal disease
human immunodeficiency virus
ejection fraction
newly diagnosed
chronic kidney disease
antiretroviral therapy
hiv infected
hiv positive
prognostic factors
hiv aids
randomized controlled trial
clinical trial
south africa
patient reported
open label